Skip to main content
Clinical Trials/NCT00200720
NCT00200720
Completed
Phase 2

Metabolic Consequences of High and Low Carbohydrate Diets

Kaiser Permanente1 site in 1 country260 target enrollmentApril 2005

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Obesity
Sponsor
Kaiser Permanente
Enrollment
260
Locations
1
Primary Endpoint
Weight loss
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

This study will examine the effects of a low carbohydrate diet versus a high carbohydrate diet on weight loss.

Detailed Description

The number of overweight and obese Americans has increased significantly in recent years. There are now many different diet plans being promoted by doctors and the media. The Atkins diet, a low carbohydrate nutritional plan, is especially popular; its advocates claim that following the diet will result in long-term weight loss with no negative effects. Another diet, called the Dietary Approaches to Stop Hypertension (DASH) diet, is a high carbohydrate diet designed to help treat and prevent high blood pressure. However, more thorough investigation of these claims is needed. This study will compare the short- and long-term effects of the Atkins diet to the (DASH) diet. This trial will enroll overweight and obese participants. This study will last 30 months and will comprise two phases. Participants will be randomly assigned to either the Atkins or DASH diet for 30 months. During Phase 1, all participants will undergo 6 months of weekly group therapy to encourage weight loss. Phase 2 is a weight loss maintenance phase. During Phase 2, participants will have monthly meetings with a therapist for weight loss support. Study visits will occur at study entry and at Months 3 and 30. At each study visit, weight measurements, blood and urine collection, and x-rays will occur to determine participants' weight loss, cardiovascular health, kidney function, and bone density.

Registry
clinicaltrials.gov
Start Date
April 2005
End Date
June 2010
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Body mass index (BMI) of 27 to 50
  • Fasting glucose less than 126 mg/dl
  • Total fasting cholesterol less than 260 mg/dl
  • Total fasting triglycerides less than 400 mg/dl
  • Permission of primary care provider to participate in the study
  • Normal liver and kidney function
  • Willing to modify diet and other health behaviors
  • Willing to use an acceptable method of contraception for the duration of the study

Exclusion Criteria

  • Any medical condition that may make weight loss medically inadvisable
  • Weigh more than 400 lbs
  • History of kidney failure
  • Current use of more than 3 blood pressure medications
  • Change in blood pressure medications within 3 months prior to study entry
  • Diagnosis of cardiovascular disease within 6 months prior to study entry
  • Cancer diagnosis within 2 years of study entry. Participants with basal cell skin cancer are not excluded.
  • History of psychiatric hospitalization within 2 years prior to study entry
  • Consumption of more than three alcoholic drinks a day
  • Type I or II diabetes

Outcomes

Primary Outcomes

Weight loss

Time Frame: monthly

Excess weight loss (greater than 5 pounds a week)would trigger patient assessment.

Secondary Outcomes

  • Risk of cardiovascular disease(Every six months)
  • bone health(end of study)
  • kidney function(every six months)
  • neuroendocrine mechanisms of hunger and satiety(end of study)

Study Sites (1)

Loading locations...

Similar Trials